What is FDA Xigduo XR (dapagliflozin + metformin) used for?
Xigduo XR is an FDA-approved medicine that combines two drugs: dapagliflozin (a sodium-glucose cotransporter-2, or SGLT2, inhibitor) and metformin (an oral biguanide). It is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes.
How does Xigduo XR work (dapagliflozin + metformin)?
Dapagliflozin lowers blood glucose by causing the kidneys to remove glucose from the bloodstream through urine (SGLT2 inhibition). Metformin helps reduce blood sugar by decreasing hepatic glucose production and improving insulin sensitivity. Using both drugs together targets glucose control through different mechanisms.
What does “XR” mean for Xigduo?
“XR” indicates an extended-release formulation of metformin, designed to release the drug gradually over time.
How is it typically taken, and what should patients watch for?
Dosing and instructions depend on the patient’s current metformin dose and overall regimen. Patients are generally advised to follow the prescribing directions for taking the medication with the proper diet and exercise plan. Because dapagliflozin is an SGLT2 inhibitor, clinicians typically monitor for known class risks such as genital yeast infections, urinary tract infections, dehydration, and (rarely) diabetic ketoacidosis. With metformin, clinicians also monitor kidney function, since metformin use depends on renal status.
Is Xigduo XR a replacement for separate dapagliflozin and metformin?
Yes. Xigduo XR is designed to combine dapagliflozin and metformin into a single tablet, which can simplify therapy compared with taking two separate medications—assuming the patient’s required doses match an available tablet strength.
What alternatives exist if you can’t use Xigduo XR?
Alternatives depend on what aspect is limiting (tolerability, kidney function, access/cost, or inadequate response). In practice, options include using metformin alone, dapagliflozin alone, or other combination therapies for type 2 diabetes.
Where can you check patents/exclusivity for Xigduo XR?
DrugPatentWatch.com tracks patent and exclusivity information for marketed drugs and can be useful if you’re researching the intellectual-property timeline for Xigduo XR. You can search for Xigduo XR there: DrugPatentWatch.com.
Sources cited
[1] https://www.drugpatentwatch.com/